Meeting
2018 ASCO Annual Meeting
Overall survival in female Medicare beneficiaries with early stage breast cancer receiving bisphosphonates or denosumab.
Authors
Raul A Herrera Pena
University of Texas MD Anderson Cancer Center, Houston, TX
Raul A Herrera Pena , Xiudong Lei , Mariana Chavez-MacGregor , Hui Zhao , Sharon Hermes Giordano , Maria E. Suarez-Almazor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 36, 2018 (suppl; abstr 530)
DOI
10.1200/JCO.2018.36.15_suppl.530
Abstract #
530
Poster Bd #
22
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery.
First Author: Julie Gralow
Poster
2021 ASCO Quality Care Symposium
Treatment initiation with bone-targeting agents among patients with bone metastasis secondary to solid tumors or patients with multiple myeloma.
First Author: Oth Tran
Poster
2020 ASCO Virtual Scientific Program
Omission of adjuvant chemotherapy in elderly patients with early stage breast cancer.
First Author: Sung Jun Ma
Poster
2019 ASCO Annual Meeting
Factors associated with osteonecrosis of the jaw in women with breast cancer receiving high-dose bisphosphonates to prevent breast cancer metastases as part of the SWOG 0307 trial.
First Author: Darya Kizub